Cargando…

Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer

Anaplastic thyroid cancer (ATC) is one of the most aggressive human malignancies, with no effective treatment currently available. Previously, we identified agents active against ATC cells, both in vitro and in vivo, using quantitative high-throughput screening of 3282 clinically approved drugs and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lisa, Boufraqech, Myriem, Lake, Ross, Kebebew, Electron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941332/ https://www.ncbi.nlm.nih.gov/pubmed/26934320 http://dx.doi.org/10.18632/oncotarget.7760

Ejemplares similares

Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
por: Zhang, Lisa, et al.
Publicado: (2015)

Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis
por: Sadowski, Samira M., et al.
Publicado: (2015)

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
por: Nilubol, Naris, et al.
Publicado: (2018)

SAT-568 Glutamine Metabolism Is a New Potential Therapeutic Target in Aggressive Thyroid Cancer
por: Patel, Dhaval, et al.
Publicado: (2019)

LOX is a novel mitotic spindle-associated protein essential for mitosis
por: Boufraqech, Myriem, et al.
Publicado: (2016)

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019)

MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
por: Xiong, Yin, et al.
Publicado: (2014)

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome
por: Boufraqech, Myriem, et al.
Publicado: (2019)

CUDC-101 is a potential target inhibitor for the EGFR-overexpression bladder cancer cells
por: Wang, Zhenxing, et al.
Publicado: (2023)

Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples
por: Gara, Sudheer Kumar, et al.
Publicado: (2015)

Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells
por: Moertl, Simone, et al.
Publicado: (2019)

New Therapies for Advanced Thyroid Cancer
por: Laha, Diprajan, et al.
Publicado: (2020)

ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
por: Jain, Meenu, et al.
Publicado: (2014)

68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor
por: Shell, Jasmine, et al.
Publicado: (2018)

miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2015)

Biomarkers in Thyroid Tumor Research: New Diagnostic Tools and Potential Targets of Molecular-Based Therapy
por: Gimm, Oliver, et al.
Publicado: (2011)

Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma
por: Saburi, Masuho, et al.
Publicado: (2020)

CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells
por: Huegel, Julianne, et al.
Publicado: (2022)

Editorial: Translational Research in Thyroid Cancer
por: Vasko, Vasyl, et al.
Publicado: (2020)

Antitumor Activity of Berberine by Activating Autophagy and Apoptosis in CAL-62 and BHT-101 Anaplastic Thyroid Carcinoma Cell Lines
por: Shi, Xiang-Zhe, et al.
Publicado: (2023)

Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic
por: Al-Mansour, Fares, et al.
Publicado: (2023)

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016)

MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2011)

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016)

Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells
por: Shi, Yonghua, et al.
Publicado: (2016)

Medullary Thyroid Cancer: It is a pain in the neck?
por: Guerrero, Marlon A., et al.
Publicado: (2011)

Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature
por: Neychev, Vladimir, et al.
Publicado: (2017)

Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug Screening
por: Liao, Wei, et al.
Publicado: (2021)

Adrenocortical Carcinoma and Synchronous Malignancies
por: Guerrero, Marlon A., et al.
Publicado: (2010)

To the editor
por: Kebebew, Electron, et al.
Publicado: (2017)

Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma
por: Gao, Minjie, et al.
Publicado: (2016)

KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer
por: Jain, Meenu, et al.
Publicado: (2011)

CUDC‐907 blocks multiple pro‐survival signals and abrogates microenvironment protection in CLL
por: Chen, Yixiang, et al.
Publicado: (2018)

Anaplastic thyroid cancer: outcomes of trimodal therapy
por: Houlihan, Orla A., et al.
Publicado: (2021)

Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells
por: Hong, Jung Min, et al.
Publicado: (2014)

Inhibition of X-linked inhibitor of apoptosis protein suppresses tumorigenesis and enhances chemosensitivity in anaplastic thyroid carcinoma
por: Liu, Yao, et al.
Publicado: (2017)

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5
por: Han, Bo, et al.
Publicado: (2015)

Overexpression of miR-101 promotes TRAIL-induced mitochondrial apoptosis in papillary thyroid carcinoma by targeting c-met and MCL-1
por: Zhu, Jie, et al.
Publicado: (2017)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis
por: Champa, Devora, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u9fleclusvggd8p3l5q5s2jkbp